NuVasive Settles Patent Dispute With Orthofix, Includes $2M Settlement

NuVasive has settled a patent dispute with Orthofix and The Musculoskeletal Transplant Foundation, which includes a $2 million payment from Orthofix to cover the settlement, according to a Bloomberg Businessweek report.

Advertisement

NuVasive filed the lawsuit against Orthofix and the foundation in April, claiming the Orthofix’s Trinity Evolution infringed on property owned by NuVasive. The complete terms of the settlement were undisclosed.

Read the Bloomberg Businessweek report on the patent infringement.

Read other coverage on NuVasive:

– NuVasive Initiates Patent Infringement Lawsuit Against Globus Medical

– NuVasive Reports 2Q Revenue Up 35.2%

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.